Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Krishnamurthy NikkiSVP and Chief People Officer | UBERUber Technologies, Inc Option exercise | M | — 1,322 sh | Apr 20, 2026 |
| 9 | Audhya Paul K.CHIEF MEDICAL OFFICER |  KALVKalVista Pharmaceuticals, Inc.Option exercise | M | — 6,250 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Rainwater EvanEVP, Supp. Chain, Mfg. & Sourc | ACIAlbertsons Companies, Inc. Grant or award | A | — 17.8K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Krishnamurthy NikkiSVP and Chief People Officer | UBERUber Technologies, Inc Option exercise | M | — 2,001 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Chen ShipingDirector, Chief Operating Officer |  ALMRAlamar Biosciences, Inc.Derivative conversion | C | — 176.2K sh | Apr 20, 2026 traded Apr 20, 2026 |
| 9 | Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA |  AGXARGAN INCOption exercise | M | — 730 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Valdez Gloria LDirector |  ESEESCO TECHNOLOGIES INCGrant or award | A | $675 2 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 9 | Naclerio NicholasDirector | ALMRAlamar Biosciences, Inc. Derivative conversion | C | — 5.04M sh | Apr 20, 2026 traded Apr 20, 2026 |
| 9 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 1,158 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Hazelbaker JillSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 1,888 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Larson Robert BruceSVP & Chief Accounting Officer | ACIAlbertsons Companies, Inc. Grant or award | A | — 22.9K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Krishnamurthy NikkiSVP and Chief People Officer | UBERUber Technologies, Inc Tax withholding | F | $40K 528 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Dhanda AnujChief Tech &Transformation Off | ACIAlbertsons Companies, Inc. Grant or award | A | — 29.5K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | West TonySee Remarks | UBERUber Technologies, Inc Option exercise | M | — 1,510 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | West TonySee Remarks | UBERUber Technologies, Inc Option exercise | M | — 1,282 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Luo YulingDirector, Chief Executive Officer | ALMRAlamar Biosciences, Inc. Derivative conversion | C | — 1.02M sh | Apr 20, 2026 traded Apr 20, 2026 |
| 9 | Dewar Patrick MDirector | ESEESCO TECHNOLOGIES INC Grant or award | A | $1,898 6 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 9 | Krishnamurthy NikkiSVP and Chief People Officer | UBERUber Technologies, Inc Tax withholding | F | $34K 448 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Moriarty Thomas MEVP, M&A and Corporate Affairs | ACIAlbertsons Companies, Inc. Grant or award | A | — 36.7K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Rainwater EvanEVP, Supp. Chain, Mfg. & Sourc | ACIAlbertsons Companies, Inc. Grant or award | A | — 17.8K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Naclerio NicholasDirector | ALMRAlamar Biosciences, Inc. Derivative conversion | C | — 271.8K sh | Apr 20, 2026 traded Apr 20, 2026 |
| 9 | Bronstein ManuelDirector |  NYTNEW YORK TIMES COGrant or award | A | — 49 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Naclerio NicholasDirector | ALMRAlamar Biosciences, Inc. Derivative conversion | C | — 3.19M sh | Apr 20, 2026 traded Apr 20, 2026 |
| 9 | Naclerio NicholasDirector | ALMRAlamar Biosciences, Inc. Derivative conversion | C | — 2.86M sh | Apr 20, 2026 traded Apr 20, 2026 |
| 9 | Naclerio NicholasDirector | ALMRAlamar Biosciences, Inc. Derivative conversion | C | — 2.09M sh | Apr 20, 2026 traded Apr 20, 2026 |
| 9 | DeVries James EExecutive Vice President |  NDSNNORDSON CORPTax withholding | F | $20K 71 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Krishnamurthy NikkiSVP and Chief People Officer | UBERUber Technologies, Inc Option exercise | M | — 1,322 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Luo YulingDirector, Chief Executive Officer | ALMRAlamar Biosciences, Inc. Derivative conversion | C | — 366.0K sh | Apr 20, 2026 traded Apr 20, 2026 |
| 9 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 1,133 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Krishnamurthy NikkiSVP and Chief People Officer | UBERUber Technologies, Inc Option exercise | M | — 1,120 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Luo YulingDirector, Chief Executive Officer | ALMRAlamar Biosciences, Inc. Derivative conversion | C | — 1.22M sh | Apr 20, 2026 traded Apr 20, 2026 |
| 9 | Larson MichelleChief Merchandising Officer | ACIAlbertsons Companies, Inc. Grant or award | A | — 106.9K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Hazelbaker JillSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 1,416 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Dhanda AnujChief Tech &Transformation Off | ACIAlbertsons Companies, Inc. Grant or award | A | — 29.5K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Krishnamurthy NikkiSVP and Chief People Officer | UBERUber Technologies, Inc Option exercise | M | — 1,120 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Coen Steven P.See remarks |  DNAGinkgo Bioworks Holdings, Inc.Option exercise | M | — 587 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Naclerio NicholasDirector | ALMRAlamar Biosciences, Inc. Grant or award | A | — 5,686 sh | Apr 20, 2026 traded Apr 20, 2026 |
| 9 | Hazelbaker JillSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 2,547 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 8 | Naclerio NicholasDirector | ALMRAlamar Biosciences, Inc. Derivative conversion | C | — | Apr 20, 2026 traded Apr 20, 2026 |